RP 60556A
Alternative Names: NXL-102Latest Information Update: 17 Aug 2007
At a glance
- Originator sanofi-aventis
- Class Antibacterials; Naphthyridines; Piperazines
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gram-positive infections